Exploration of the Pathogenic Mechanism of the Factor XIII A Subunit in a Patient With Congenital Factor XIII Deficiency
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70193 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Min Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Anhui Provincial Children's Hospital (Anhui Hospital, Pediatric Hospital of Fudan University), Hefei, Anhui, C…. Hauptthemen laut MEDLINE: Factor XIII Deficiency, Factor XIII, Factor XIIIa. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Anhui Province, Scientific Research Foundation of Anhui Medical University.
Abstract (Originalsprache)
Background
Congenital factor XIII (FXIII) deficiency is an extremely rare autosomal recessive blood clotting disorder with an incidence of approximately one in two million, which is caused mainly by mutations in the F13A1 gene. Recently, we identified a Chinese family with FXIII deficiency carrying a likely pathogenic variant and explored its pathogenic mechanism.
Aim
The aim of this study was to investigate the pathogenic mechanism associated with the Ser414 mutation in the F13A1 gene.
Methods
We performed clinical diagnosis, phenotypic assessment, and genetic analysis of the proband and her family members.
Results
The FXIII antigen level of the proband was 1.3%, which was significantly lower than the normal reference range. A mutation was identified through targeted next‐generation sequencing (NGS). The effects of these variations on protein function were assessed using bioinformatics tools. Homology analysis revealed that Ser414 was also highly conserved in homologous species. Protein model analysis revealed that the Ser414Leu variation could induce alterations in the spatial structure of F13A1, potentially increasing its instability. This is the first time that F13A1 gene variants have been analyzed in a patient with FXIII deficiency, contributing to the expansion of the pathogenic variant database for congenital FXIII deficiency.
Conclusion
These findings provide valuable data accumulation that can contribute to the prevention of congenital FXIII deficiency, the exploration of potential pathogenic mechanisms, and the enrichment of genetic mutation databases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Anhui Provincial Children's Hospital (Anhui Hospital, Pediatric Hospital of Fudan University), Hefei, Anhui, China.
- Department of Clinical Laboratory Examination, Anhui Provincial Children's Hospital (Anhui Hospital, Pediatric Hospital of Fudan University), Hefei, Anhui, China.
ORCID-Profile: Min Wang, Nan Wei, Lijuan Zhu
Förderung
- Natural Science Foundation of Anhui Province
- Scientific Research Foundation of Anhui Medical University
Zitieren
APA
Wang, M., Wei, N., Chen, T., Jiang, A., Zhao, Y., Zhu, C., Zhu, L., Qu, L., & Liu, H. (2026). Exploration of the Pathogenic Mechanism of the Factor XIII A Subunit in a Patient With Congenital Factor XIII Deficiency. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70193
Vancouver
Wang M, Wei N, Chen T, Jiang A, Zhao Y, Zhu C, et al. Exploration of the Pathogenic Mechanism of the Factor XIII A Subunit in a Patient With Congenital Factor XIII Deficiency. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70193
BibTeX
@article{Wang2026,
author = {Wang, Min and Wei, Nan and Chen, Tianping and Jiang, Aoshuang and Zhao, Yinghui and Zhu, Chenglin and Zhu, Lijuan and Qu, Lijun and Liu, Hongjun},
title = {Exploration of the Pathogenic Mechanism of the Factor XIII A Subunit in a Patient With Congenital Factor XIII Deficiency},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70193}
}
EUVIMED